Search by Drug Name or NDC

    NDC 17433-9883-05 DocuSol Plus 20; 283 mg/5mL; mg/5mL Details

    DocuSol Plus 20; 283 mg/5mL; mg/5mL

    DocuSol Plus is a RECTAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Enemeez LLC DBA Summit Pharmaceuticals. The primary component is BENZOCAINE; DOCUSATE SODIUM.

    Product Information

    NDC 17433-9883
    Product ID 17433-9883_ecfb3572-aff2-375f-e053-2995a90ad328
    Associated GPIs 46500010055120
    GCN Sequence Number 071368
    GCN Sequence Number Description docusate sodium/benzocaine ENEMA 283-20MG/5 RECTAL
    HIC3 Q3S
    HIC3 Description LAXATIVES, LOCAL/RECTAL
    GCN 35131
    HICL Sequence Number 001321
    HICL Sequence Number Description DOCUSATE SODIUM/BENZOCAINE
    Brand/Generic Brand
    Proprietary Name DocuSol Plus
    Proprietary Name Suffix n/a
    Non-Proprietary Name docusate sodium w/benzocaine
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route RECTAL
    Active Ingredient Strength 20; 283
    Active Ingredient Units mg/5mL; mg/5mL
    Substance Name BENZOCAINE; DOCUSATE SODIUM
    Labeler Name Enemeez LLC DBA Summit Pharmaceuticals
    Pharmaceutical Class Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part334
    Listing Certified Through n/a

    Package

    NDC 17433-9883-05 (17433988305)

    NDC Package Code 17433-9883-5
    Billing NDC 17433988305
    Package 5 TUBE in 1 BOX (17433-9883-5) / 5 mL in 1 TUBE (17433-9883-1)
    Marketing Start Date 2013-07-12
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 08d1d3ed-1427-4a14-a2c0-91d46e258e07 Details

    Revised: 11/2022